References
- Bollini P., Andreani A., Colombo F., et al. High-dose neuroleptics: uncontrolled clinical practice confirms controlled clinical trials. British Journal of Psychiatry 1984; 144: 25–7
- Davis J. M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 1976; 33: 858–61
- Donlon P. T., Hopkin J., Tupin J. P. Overview: Efficacy and safety of the rapid neuroleptization method with injectable haloperidol. American Journal of Psychiatry 1979; 136: 273–8
- Donlon P. T., Hopkin J. T., Tupin J. P., et al. Haloperidol for acute schizophrenic patients: an evaluation of three oral regimens. Archives of General Psychiatry 1980; 37: 691–5
- Goldney R., Bowes J., Spence N., et al. The psychiatric intensive care unit. British Journal of Psychiatry 1985a; 146: 50–4
- Goldney R. D., Positano S., Spence N. D., et al. Suicide in association with psychiatric hospitalisation. Australian and New Zealand Journal of Psychiatry 1985b; 19: 177–83
- Ketai R., Matthews J., Mozdzen J. J. Sudden death in a patient taking haloperidol. American Journal of Psychiatry 1979; 136: 112–13
- Modestin J., Krapf R., Boker W. A fatality during haloperidol treatment: Mechanism of sudden death. American Journal of Psychiatry 1981; 138: 1616–17
- Neborsky R., Janowsky D., Munson E., et al. Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol: behavioural considerations. Archives of General Psychiatry 1981; 38: 195–9
- Settle E. C., Ayd F. J. Haloperidol: A quarter century of experience. Journal of Clinical Psychiatry 1983; 44: 440–8
- Tupin J. P. Focal neuroleptization: an approach to optimal dosing for initial and continuing therapy. Journal of Clinical Psychopharmacology 1985; 5(Suppl.)15–21